CareRx Announces Q4 2025 Dividend
Rhea-AI Summary
CareRx (TSX: CRRX / OTC: CHHHF) announced a CAD$0.02 per common share dividend, declared by the board on December 15, 2025. The dividend is payable on January 21, 2026 to holders of record at the close of business on December 23, 2025. The distribution is designated an eligible dividend for Canadian income tax purposes. The release notes that dividends to non-residents are subject to withholding tax (which may be reduced by treaty) and that U.S. taxation is governed by the Internal Revenue Code. Shareholders are advised to consult a tax advisor for personal tax consequences.
Positive
- Declared dividend of CAD$0.02 per common share
- Payment date set for Jan 21, 2026 with record date Dec 23, 2025
- Eligible dividend designation for Canadian tax purposes
Negative
- Dividend amount is small per share, limited near-term cash return
- Non-resident shareholders face withholding tax which may reduce net payment
News Market Reaction 1 Alert
On the day this news was published, CHHHF gained 12.96%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Toronto, Ontario--(Newsfile Corp. - December 15, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today announced that the Company's Board of Directors has declared a dividend of CAD
About CareRx Corporation
CareRx is Canada's leading provider of pharmacy services to seniors living and other congregate care communities (long-term care homes, retirement homes, assisted living facilities and group homes). We are a national organization with a large network of pharmacy fulfillment centers strategically located across the country. This allows us to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. We use best-in-class technology that automates the preparation and verification of multi-dose compliance packaging of medication, providing the highest levels of safety and adherence for individuals with complex medication regimens. We take an active role in working with our home operator partners to promote resident health, staff education and medication system quality and efficiency.
For additional information, visit www.carerx.ca or contact:
| Puneet Khanna President & Chief Executive Officer CareRx Corporation (416) 927-8400 | Suzanne Brand Chief Financial Officer CareRx Corporation (416) 927-8400 | Neil Weber Investor Relations LodeRock Advisors (647) 222-0574 neil.weber@loderockadvisors.com |

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/277989